The Center for BRCA and Related Genes provides expert clinical care to patients with BRCA-mutated and BRCA-related cancers, regardless of tumor type. We offer outstanding interdisciplinary, inter-disease group collaboration across multiple Dana-Farber disease centers. Our team of specialists works closely together to offer patients the latest therapies and clinical services, including access to innovative clinical trials.
Patients can access the Center either as new to Dana-Farber or as previously followed in a Dana-Farber disease center. Patients are evaluated by an appropriate designated expert Center physician, with a genetics evaluation as indicated.
Following expert evaluation, patients will receive recommendations for therapy and/or enter a clinical trial. Clinical samples and data collected from patients across disease centers will be used for focused correlative, translational, and laboratory-based investigation of BRCA and BRCA-related genes.